
TB-500
Synthetic thymosin β4 peptide supplied as a reference standard for in-vitro cell-motility research.
Every lot of TB-500 is analysed against the specification below before any vial is released.
| Parameter | Result | Method | |
|---|---|---|---|
| Appearance | White lyophilised powder | Visual | White lyophilised powder |
| Purity | ≥ 99.00% | HPLC | ≥ 95% |
| Identity | Confirmed | HPLC / MS | Meets specification |
| Heavy metals | Not detected | ICP-MS | Pass |
| Sterility | No growth | PCR | Pass |
| Endotoxin | Within limit | USP <85> | Report |
Analysis is carried out on every lot before release. If you are supplying material onward, run your own confirmatory testing on arrival — our work supports yours, it does not replace it.
- Presentation
- 10 mg / vial
- Molecular formula
- C212H350N56O78S
- Molecular weight
- 4963.5 g/mol
- CAS
- 77591-33-4
- Grade
- Research use only (RUO)
For laboratory and research purposes only. Not for human or animal consumption.
Peer-reviewed research on TB-500, indexed in PubMed. Listed so you can read the primary sources directly.
- Int ImmunopharmacolThymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies
Bock-Marquette I, Maar K, Maar S et al.
- Int ImmunopharmacolThymosin beta 4: A potential novel adjunct treatment for bacterial keratitis
Sosne G, Berger EA
- Int ImmunopharmacolThymosin beta-4 - A potential tool in healing middle ear lesions in adult mammals
Bako P, Lippai B, Nagy J et al.
- Curr Med ChemThymosin β4: A Multi-Faceted Tissue Repair Stimulating Protein in Heart Injury
Bjørklund G, Dadar M, Aaseth J et al.
- Expert Opin Biol TherThymosin beta 4 and the eye: the journey from bench to bedside
Sosne G
- Vitam HormThymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells
Kim J, Jung Y
These papers are the published research on this molecule. They are not a claim about this product, and nothing here describes an intended use. All material is supplied for laboratory research only.
